Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Antipodean Pharmaceuticals Inc.
DescriptionOral formulation of mitoquinone
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationLiver disease
Indication DetailsTreat liver inflammation; Treat non-alcoholic fatty liver disease (NAFLD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today